510(k) device
Storz Medical Duolith SD1 T-Top & Tower System with C-Actor Sepia Handpiece
Storz Medical AG · Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL, Class II) · First FDA decision Feb 21, 2021, newest Feb 21, 2021Chronic wounds and ulcersDiabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
13
Naming "Medical Duolith SD1"
MAUDE reports
0
Brand "Medical Duolith SD1", since 2015
PubMed studies
0
Mentioning "Medical Duolith SD1"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Storz Medical Duolith SD1 T-Top & Tower System with C-Actor Sepia Handpiece
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K202112 · Decided Feb 21, 2021 · 206 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy)National determinationOn the books70.2.1Updated Aug 17, 2023
- Treatment of Decubitus UlcersNational determinationOn the books270.4Updated Apr 20, 2020
- Extracorporeal Shock Wave Therapy (ESWT)Local determinationIn effectL38775Palmetto GBAUpdated Sep 6, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Medical Duolith SD1", any status and sponsor, newest update first.
- Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic PainPivotal-lookingRecruiting
The Cleveland ClinicAcademic, hospital or other
NCT05868668 · 186 participants (planned) · Start Sep 19, 2023 · Primary completion Dec 2026
Device: Focused shockwave; Radial wave and 1 more · For: Erectile Dysfunction Due to Arterial Insufficiency; Erectile Dysfunction; Erectile Dysfunction Due to Arterial Disease and 4 more
Sites: Cleveland, Ohio
- Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With VulvodyniaRecruiting
Nantes University HospitalAcademic, hospital or other
NCT07553715 · 50 participants (planned) · Start Apr 1, 2026 · Primary completion Dec 1, 2026
Device: Low-Intensity Focal Extracorporeal Shock Wave Therapy · For: Vulvodynia
Sites: Nantes, France
University of AlbertaAcademic, hospital or other
NCT05226637 · 40 participants (planned) · Start Apr 29, 2022 · Primary completion Dec 2026
Device: ESWT (extra-corporeal shock wave therapy); Sham : The ESWT device (Storz Medical Duolith SD1), · For: Spasticity, Muscle
Sites: Edmonton, Canada
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medical Duolith SD1", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PZL
2 reports: 0 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Medical Duolith SD1"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PZL.
- OW100SSoftwave/Trt, LLC · 510(k) 2024
- DOLORCLAST Focused Shock WavesE.M.S Electro Medical Systems S.A · 510(k) 2025
- CS-Pro MEDCurative Sound Therapeutics · 510(k) 2025
- OrthoGold 100Tissue Regeneration Technologies, LLC · 510(k) 2020
- OrthoGoldTissue Regeneration Technologies · 510(k) 2019
- dermaPACE SystemSanuwave, Inc. · De Novo 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.